Details of the Drug Reposition

General Information of This Drug (ID: DM3XU74)

Drug Name
Dornase Alfa   DM3XU74
Synonyms Pulmozyme (TN)
Therapeutic Class
Enzyme Replacement Agents

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Cystic fibrosis DIS2OK1Q CA25 Approved [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Coronavirus Disease 2019 (COVID-19) DISM7GNX 1D6Y Phase 2 [2]
------------------------------------------------------------------------------------

References

1 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (BLA) 103532.
2 ClinicalTrials.gov (NCT04359654) Nebulised Dornase Alfa for Treatment of COVID-19. U.S. National Institutes of Health.